Blueprint Medicines Corporation (BPMC) financial statements (2021 and earlier)

Company profile

Business Address 45 SIDNEY STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,5501,356650750548595667
Cash and cash equivalents6855652893751148982
Short-term investments187192233292370404510
Other undisclosed cash, cash equivalents, and short-term investments678598129846410174
Receivables74435121
Inventory, net of allowances, customer advances and progress billings9643   
Inventory9643   
Other undisclosed current assets(638)(564)(90)(53)(32)(83)(55)
Total current assets:928842568705517514613
Noncurrent Assets
Operating lease, right-of-use asset68697072737475
Property, plant and equipment34353738383834
Long-term investments and receivables678598128846410174
Long-term investments678598128846410174
Restricted cash and investments5555555
Other noncurrent assets698101066
Total noncurrent assets:791717249209191224194
TOTAL ASSETS:1,7181,558817914708738807
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities110929082938371
Accounts payable4368527
Accrued liabilities106898474898064
Deferred revenue131089654
Debt   7776
Other undisclosed current liabilities887    
Total current liabilities:131110105981069482
Noncurrent Liabilities
Long-term debt and lease obligation82848688899193
Operating lease, liability82848688899193
Liabilities, other than long-term debt36444545483740
Deferred revenue29353737403640
Other liabilities7998800
Total noncurrent liabilities:118128131132137127133
Total liabilities:248238236231243222214
Stockholders' equity
Stockholders' equity attributable to parent1,4701,320581683464516593
Common stock0000000
Additional paid in capital2,1071,8681,7621,7391,4121,3951,376
Accumulated other comprehensive income (loss)(5)(2)(1)(0)(3)11
Accumulated deficit(631)(546)(1,180)(1,056)(945)(879)(785)
Total stockholders' equity:1,4701,320581683464516593
TOTAL LIABILITIES AND EQUITY:1,7181,558817914708738807

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues34745865295
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(0)(0)   
Gross profit:34745865295
Operating expenses(120)(112)(133)(120)(121)(107)(109)
Operating income (loss):(86)633(125)(114)(69)(98)(104)
Nonoperating income1123344
Other nonoperating income (expense)0(0)(0)(0)(11)44
Interest and debt expense     (0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes    0  
Income (loss) from continuing operations before income taxes:(85)634(123)(111)(66)(94)(100)
Income tax expense(1)(0)     
Income (loss) before gain (loss) on sale of properties:(86)634(123)(111)(66)(94)(100)
Other undisclosed net loss    (0)  
Net income (loss):(86)634(123)(111)(66)(94)(100)
Other undisclosed net income attributable to parent     00
Net income (loss) available to common stockholders, diluted:(86)634(123)(111)(66)(94)(100)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(86)634(123)(111)(66)(94)(100)
Other comprehensive income (loss) (1)(1)2 (0)1
Other undisclosed comprehensive income    1  
Comprehensive income (loss):(86)633(125)(108)(66)(95)(99)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)(0)0(0)(4)00
Comprehensive income (loss), net of tax, attributable to parent:(89)633(125)(108)(70)(95)(99)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: